Understanding Tremfya for Ulcerative Colitis
Tremfya (guselkumab) is revolutionizing the treatment of moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. By targeting interleukin-23, this medication reduces inflammation and eases symptoms, offering flexible administration options. Explore the mechanism of action, patient preferences, side effects, and financial considerations associated with Tremfya to better manage ulcerative colitis. Understanding Ulcerative Colitis Treatment […]
3 minute read